APP
AppLovin Corporation
APP's fundamentals are strong and it looks cheap: trading at 26x earnings, less than half its usual 66x. Analysts expect strong earnings growth.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
APP Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
APP's revenue, profitability, cash flow and balance sheet are all currently strong.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
APP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 20x | $394 | — |
| Current | 26x | $394 | — |
| Cheap | 42x | $618 | +57% |
| Fair | 66x | $978 | +148% |
| Expensive | 137x | $2,040 | +418% |
Historical ranges are pointers, not guarantees.
APP's PE is in its cheap range at 26x. If earnings grow as analysts expect, today's price would be 20x next year's earnings.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
APP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Moderate | |
| Moderate |
APP has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
APP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $19.62 | +32% |
| Q3 2026 | $14.86 | +81% |
| Q2 2026 | $13.01 | +85% |
| Q1 2026 | $11.64 | +110% |
| Q4 2025 | $9.75 | +115% |
| Q3 2025 | $8.23 | +151% |
| Q2 2025 | $7.03 | +202% |
| Q1 2025 | $5.53 | +233% |
| Q4 2024 | $4.53 | +362% |
APP has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
APP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +55% |
| Q2 2026 | $1.9B | +53% |
| Q1 2026 | $1.8B | +24% |
| Q4 2025 | $1.7B | +21% |
| Q3 2025 | $1.4B | +17% |
| Q2 2025 | $1.3B | +17% |
| Q1 2025 | $1.5B | +40% |
| Q4 2024 | $1.4B | +44% |
APP's revenue has grown year over year for 13 quarters in a row: $2.2B last quarter, up 55% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 78% | +1.4 points |
| Q2 2026 | 78% | +1.6 points |
| Q1 2026 | 78% | +33 points |
| Q4 2025 | 77% | +33 points |
| Q3 2025 | 77% | +32 points |
| Q2 2025 | 76% | +40 points |
| Q1 2025 | 45% | +13 points |
| Q4 2024 | 44% | +16 points |
APP has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over APP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
APP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +36% |
| Q2 2026 | $869M | +13% |
| Q1 2026 | $1.3B | +55% |
| Q3 2025 | $1.1B | +91% |
| Q2 2025 | $772.2M | +70% |
| Q1 2025 | $831.7M | +112% |
| Q3 2024 | $550.7M | +177% |
| Q2 2024 | $454.5M | +101% |
APP has the edge over HIMS on cash flow, with more consistent year-over-year improvement.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
APP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -2.3M shares |
| 1 year | -1.8% | -6.2M shares |
| 3 years | -6.2% | -22.1M shares |
| 5 years | -13% | -49.6M shares |
| Available history | +67% | +134M shares |
APP has 335M diluted shares, down 1.8% from a year ago, with $3.2B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.3B |
| Q2 2026 | $551.2M |
| Q1 2026 | $981.7M |
| Q4 2025 | $417.6M |
| Q3 2025 | $501.9M |
| Q2 2025 | $271.5M |
| Q1 2025 | $1B |
| Q4 2024 | $625,000 |
APP spent $3.2B buying back its own shares over the past year, up 82% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over APP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
APP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.2x | Healthy |
APP's net debt is less than a year of its operating earnings (EBITDA).
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
APP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 56.4 | Neutral |
APP's weekly RSI is 53 (neutral) and its Stochastic is 56 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
APP PE vs Technology Sector
| Metric | APP | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 28x | 4.9% below |
| PE % | 7 | 42 | 35 pts below |
APP is trading at 26x earnings, in line with the Technology sector's median of 28x.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
APP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $299.5 | 31% above |
| 20 week MA | $344.0 | 14% above |
| 50 week MA | $443.5 | 11% below |
| 100 week MA | $429.4 | 8.3% below |
| 200 week MA | $250.0 | 57% above |
APP has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
APP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $61.0 | $93.8 | +54% |
| 2022 | $93.8 | $9.84 | -90% |
| 2023 | $9.84 | $39.9 | +305% |
| 2024 | $39.9 | $335.2 | +741% |
| 2025 | $335.2 | $714.2 | +113% |
| 2026 YTD | $714.2 | $393.7 | -45% |
APP's yearly returns have swung widely, from +741% in 2024 to −90% in 2022. It's down 45% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over APP on returns for 2026, with the stronger performance.